SCMP : Meet Cambricon: how 2 ‘genius brothers’ created China’s potential rival t

Meet Cambricon: how 2 ‘genius brothers’ created China’s potential rival to Nvidia
The Chen brothers were students in an elite CAS ‘genius youth class’, a special programme designed to train top local talent

The hottest company in China right now is Cambricon Technologies, an artificial intelligence chipmaker whose stock has surged about 10-fold over the past two years, driven by expectations that it could be a serious challenger to Nvidia in the mainland market.

The frenzy over Cambricon, whose stock is trading at an eye-watering trailing 12-month price-to-earnings ratio above 4,000 – compared to under 60 for Nvidia – reflects a growing belief in China that the country is on a path to develop an AI ecosystem independent from US hardware.

Chinese model developer DeepSeek’s recent suggestion that the country’s “next-generation home-grown AI chips” were just around the corner has ignited enthusiasm about Cambricon’s prospects, analysts said.

“The rapid surge in Cambricon’s valuation reflects not just its recent growth but also heavy anticipation of future potential,” said Ray Wang, research director with a focus on the global semiconductor industry at Futurum Group. “This optimism is largely driven by regulatory and geopolitical shifts, strong domestic AI demand, and the latest DeepSeek optimisations for local hardware.”

The company’s core business is the development and design of AI chips for cloud servers, edge devices and terminals, as well as data-centre clusters. Cambricon is reportedly developing its flagship Siyuan 690, set to succeed the Siyuan 590 series launched in 2023. The new chip is expected to approach the capabilities of Nvidia’s H100.

Cambricon was founded in 2016 by two brothers, Chen Yunji and Chen Tianshi, who are now 42 and 40 years old, respectively. Born in Nanchang, the capital of Jiangxi province, they both went on to work at the Chinese Academy of Sciences (CAS), the country’s top science research agency.

The Chen brothers were students in the academy’s elite “genius youth class”, a special education programme designed to train top local talent, before they joined the academy’s Institute of Computing Technology. The elder brother focused on semiconductors while the younger turned to AI.

Both shared a passion for chip design. According to an interview with the elder Chen published by official media China Science Daily in September 2024, the brothers shared “laughter and tears” in jointly working on deep-learning processors, also known as AI accelerators.

One time, they argued about a research issue so fervently that they ended up in a physical fight, according to the older Chen. “As brothers, we can put aside all pretence and honestly face all kinds of problems,” he was quoted as saying by the newspaper. “Perhaps that’s the reason we can rapidly advance our cross-disciplinary research into chip design and AI algorithms.”

The pair began exploring the idea of “AI plus chip” around 2010, in which they studied the use of chips to accelerate deep learning algorithms.

In 2014, their co-authored paper on machine learning won the top award at ASPLOS, a leading computer architecture conference. With support from CAS, they taped out a prototype deep learning processor the following year, calling it Cambricon, after the Cambrian era of rapid evolutionary expansion.

The younger Chen is now Cambricon’s chairman and largest individual shareholder, directly owning a 28.6 per cent stake, making him one of the richest people in China with a personal net worth of US$20 billion. The company’s second-largest shareholder is a CAS-affiliated asset manager, with 15.7 per cent. The elder Chen returned to academia shortly after the company’s founding and is now the head of the CAS Laboratory of Processors, the top Chinese lab in the field.

Recent financial data shows that Cambricon’s business is starting to take off.

In the fourth quarter of 2024, the company recorded its first quarterly profit of 272 million yuan (US$38 million), reversing years of losses, while revenue rose 75.5 per cent year on year to 989 million yuan.

In the first quarter of this year, revenue surged 42 times compared with a year earlier, according to a filing to the Shanghai Stock Exchange, while income was 355 million yuan compared with a loss of 226 million yuan a year ago.

The China Academy of Information and Communications Technology, a think tank affiliated with the Ministry of Industry and Information Technology, listed the firm as one of eight hardware suppliers with DeepSeek-compatible products.

China’s AI momentum picked up last week, when DeepSeek said its latest V3.1 model was trained using a novel FP8 data format, which was “suitable for home-grown chips soon to be released”, without naming suppliers.

The comments came after reports that Nvidia paused production of China-specific H20 chips, which Beijing has flagged as a security concern, further fuelling local enthusiasm for Cambricon.

Like Nvidia, Cambricon designs chips and outsources the wafer manufacturing to foundries. Nvidia’s AI chips are exclusively made by the world’s No 1 foundry, Taiwan Semiconductor Manufacturing Company (TSMC).

Cambricon was added to Washington’s trade blacklist in December 2022, restricting it from acquiring US core technology, including using foundry services offered by TSMC.
There is no public information about what foundry Cambricon uses for its chips, but since it cannot access TSMC, it is likely that it relies on mainland foundries such as Semiconductor Manufacturing International Corporation or Hua Hong Semiconductor.

Cambricon’s market value is now US$70 billion, about 70 per cent of Intel’s US$107 billion. It took Intel 28 years to reach the market cap of what Cambricon did in nine years.

Goldman Sachs over the weekend reiterated its “buy” rating on Cambricon, lifting its 12-month price target by 50 per cent to 1,835 yuan from 1,223 yuan. The bank cited China’s cloud providers stepping up capital expenditure, customers diversifying away from US chips, and Cambricon’s pledge to invest 4.5 billion yuan in AI chips and software over the next three years.

Brokerages have followed with bullish calls. Guosen Securities expects revenues of 5.0 billion yuan for 2025, 7.3 billion yuan for 2026 and 10.2 billion yuan 2027. “The company’s rapid revenue growth reflects its success in expanding markets and enabling AI deployment,” Guosen wrote in a June research note, highlighting robust demand for domestic computing power.

FT : Eli Lilly’s weight-loss pill meets target in key diabetes trial

Eli Lilly’s weight-loss pill meets target in key diabetes trial
Results from US pharma group show oral drug reduced body weight by 10.5% on average

US pharmaceutical group Eli Lilly has announced that the latest trial of its anti-obesity pill has met weight-loss targets, boosting its plans to seek approval for the drug as it fights for market dominance with rival Novo Nordisk.

Lilly said on Tuesday that its orforglipron pill reduced the body weight of people who were overweight and suffered from diabetes by 10.5 per cent on average. It noted that the side effects were similar to those for its injectable weight-loss drugs.

The results come after the market was disappointed earlier this month by the results of an orforglipron trial in people without diabetes: participants lost an average of 12.4 per cent of their body weight, at the lower end of expectations.

The results will intensify its long-running battle for market dominance with Novo Nordisk, which in May submitted its first weight-loss pill for US regulatory approval. Novo’s pill helped patients with diabetes lose about 9.2 per cent of their body weight at the highest dose in a trial.

Kenneth Custer, an executive vice-president at Lilly, said the company anticipated that it would submit orforglipron for approval by the US Food and Drug Administration later this year. Analysts have said the FDA could give the go-ahead next year.

No oral versions of the new generation of blockbuster drugs have received approval to treat obesity yet, so positive trial results from Lilly and its rivals are being closely watched.

A weight-loss pill would also cost less to manufacture and store, as the current injectable versions need to be refrigerated.

Obese and overweight people who also have diabetes can find it more difficult to lose weight, depending on their age and other factors. “We are really excited to see [the] 10.5 per cent weight loss,” said Custer.

But investors have shown concern. The earlier Lilly trial results for orforglipron pushed its shares to their lowest level since January 2024. At the close on Monday, its shares were down 10.6 per cent this year, while Copenhagen-listed Novo Nordisk has fallen 43.7 per cent over the same period.

After the disappointing earlier results, Lilly executives and board directors bought a combined $4.5mn of its stock. It was the most insider buying at the company in a single quarter since 2019, according to VerityData.

Globally, “probably more than 1bn people could potentially benefit from these medicines”, said Custer, referring to all obesity drugs. “There is no way we are going to be able to get there with injectables.”

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • SATS +55.4%, DOMO +7.9%, KNTK +4.8%, TLN +4.6%, IBKR +4.1%, LEU +3%, WOLF +3%, AMD +2.7%, ICFI +2.3%, BMO +2%, WU +1.8%, BF.A +1.4%, NA +1.4%, BHLB +1.2%, NVTS +1.1%, NVS +1.1%, T +1%, SMTC +1%, HEI +1%, BNS +1%, BA +0.7%, IBM +0.7%
  • Gapping down:
    • EH -8.7%, BWLP -2.8%, BEKE -1.9%, ZIP -1.6%, BRKL -0.8%, RCKT -0.8%, BKE -0.7%

>>> BIT Mining launches DOLAI, a U.S. dollar-backed stablecoin

BIT Mining launches DOLAI, a U.S. dollar-backed stablecoin

Key Highlights of the Stablecoin Launch
  • Compliant, Institutional-Grade Stablecoin: DOLAI stablecoin is jointly introduced by Bit Mining and Brale in pursuant to existing U.S. regulatory requirements, ensuring 1:1 dollar collateralization with reserves held in cash and short-term U.S. Treasuries. The infrastructure incorporates robust AML/KYC and OFAC screening to facilitate compliance with current U.S. regulatory requirements.
  • Seamless Integration with AI Agents, Multi-chain Interoperability, and Banking:
    AI-Agent Integration: DOLAI is not only a compliant, dollar-backed stablecoin, but also an AI-native payment currency, designed to integrate with emerging AI payment protocols (e.g., x402) that enable autonomous machine-to-machine transactions. This positions DOLAI to serve as a settlement layer for the agentic economy, where AI agents can in the future independently request services, verify value, and complete payments without human intervention.
  • Multi-chain Interoperability: DOLAI is natively available on Solana, with API connectivity enabling seamless swaps across multiple blockchains (Ethereum, Base, Canton, and more) and 20+ stablecoins (e.g., USDC, USDP).
  • Banking rails: Institutions can mint and redeem DOLAI directly via ACH or wire transfers, bridging traditional finance with crypto-native settlement.

TechCrunch : Tesla could have avoided that $242.5M Autopilot verdict, filings sh

Tesla could have avoided that $242.5M Autopilot verdict, filings show

Months before a jury awarded a $242.5 million verdict against Tesla over its culpability in a 2019 fatal crash, the automaker had a chance to settle for $60 million. Instead, Tesla rejected that offer, according to new legal filings that were first reported by Reuters.

The settlement proposal, which was made in May, was disclosed in a filing that requested Tesla cover legal fees for the plaintiffs in the case.


Earlier this month, a jury in federal court in Miami found Tesla partly to blame for a fatal 2019 crash that involved the use of the company’s Autopilot driver assistance system. One person was killed when a Tesla Model S with Autopilot engaged plowed through an intersection and hit a Chevrolet Tahoe. The crash victims, Neima Benavides Leon and her boyfriend Dillon Angulo, were standing outside the vehicle on the shoulder at the time. Leon was killed while Angulo was severely injured.

The driver, who was not a defendant in this case, was sued separately for his responsibility. The lawsuit filed in 2021 against Tesla centered on Autopilot, which was engaged but did not brake in time to avoid going through the intersection. The jury assigned the driver two-thirds of the blame and attributed one-third to Tesla. As part of the verdict, the jury awarded the $242.5 million verdict as part of its decision.

Tesla, in a statement provided to TechCrunch earlier this month, said it plans to appeal the verdict “given the substantial errors of law and irregularities at trial.”
TechCrunch has reached out to the plaintiffs’ attorneys as well as Tesla. An outside PR firm that previously provided statements on Tesla’s behalf declined to comment and directed TechCrunch to the company’s press address. Tesla disbanded its communications team several years ago.

The lawsuit, case 1:21-cv-21940-BB, was filed in 2021 in the U.S. District Court for the Southern District of Florida.

>>> Europe : Brokers Upgrades & Downgrades - 26th of August 2025 V2(+)

>>> Up
* Bouygues Raised to Overweight at JPMorgan; PT 49 euros
* Cemex ADRs Raised to Overweight at JPMorgan; PT $10.50
* Clarkson PT Raised to 4,350 pence at Deutsche Bank (+)
* DiaSorin Raised to Overweight at Morgan Stanley; PT 101 euros
* Huber+Suhner Raised to Add at AlphaValue/Baader
* Oxford Biomedica PT Raised to 930 pence from 800 pence at RBC
* Pfisterer Holding PT Raised to 74 euros at Berenberg
* PVA TePla PT Raised to 30 euros from 26 euros at Deutsche Bank (+)
* TUI Raised to Add at AlphaValue/Baader (+)
* Var Energi Raised to Buy at SpareBank; PT 38 kroner (+)
* VF Corp Raised to Outperform at Baird; PT $20

>>> Down
* AB Foods Cut to Sell at Deutsche Bank; PT 2,130 pence
* BioMerieux Cut to Equal-Weight at Morgan Stanley; PT 124 euros
* Commerzbank Cut to Underperform at BofA; PT 33 euros
* HelloFresh Cut to Add at AlphaValue/Baader
* KCC Cut to Neutral at Clarksons; PT 80 kroner (+)
* Kingfisher Cut to Hold at Deutsche Bank; PT 280 pence
* Odfjell Cut to Neutral at Clarksons; PT 125 kroner (+)
* Wickes Cut to Sell at Deutsche Bank; PT 195 pence
* Wix.com Cut to Sell at Deutsche Bank; PT $195 (+)

>>> Initiation
* Alphabet Reinstated Buy at William O'Neil
* Amer Sports Reinstated Buy at William O'Neil
* Argenx Rated New Buy at William O'Neil
* Bico Group Reinstated Suspended Coverage at Stifel
* EnQuest Rated New Buy at Peel Hunt; PT 24 pence
* Krones Rated New Buy at Jefferies; PT 175 euros
* SolGold Rated New Speculative Buy at Canaccord; PT 46 pence (+)
* Tecno SpA Societa Benefit Rated New Buy at Intesa Sanpaolo (+)

>>> Call
* BofA, UBS See Small-Cap Outperformance as Powell Turns Dovish
* Bouygues Overhangs Clearing, JPMorgan Upgrades to Overweight
* DiaSorin Raised, BioMerieux Cut as Morgan Stanley Flips Ratings
* Krones Set for Above Market Growth, Rated New Buy at Jefferies
* Zurich Airport Seen Higher on Strong 1H Performance: Vontobel (+)

>>> What to look at today - 26th of August 2025

The dollar pared most of its losses as Federal Reserve Governor Lisa Cook said she won’t resign after President Donald Trump moved to oust her. A gauge of the dollar retreated as much as 0.3% and gold rose as much as 0.6% after Trump posted on his Truth Social account that Cook will be removed effective immediately. The greenback then cut some of the losses and gold trimmed gains after Cook said she won’t resign. Asian stocks fell 0.7% and equity-index futures for US and Europe retreated. The Treasury curve steepened, with a drop in two-year yields reflecting growing speculation of a Fed interest-rate cut as soon as next month, while 30-year yields climbed on concern looser monetary policy would risk fueling inflation. French bond futures opened lower in Asia trading. Trump’s move adds to the negative sentiment toward US assets, after his tariff war and widening deficit revived a “Sell America” theme earlier this year and Wall Street questioned US exceptionalism. Traders have been seeking alternatives to the dollar, the world’s reserve currency, and Treasuries, and any perception of eroding Fed independence could accelerate that shift. Trump’s announcement came after the US Department of Justice indicated it planned to investigate Cook, following a criminal referral from Federal Housing Finance Agency Director Bill Pulte alleging that she may have committed mortgage fraud. UBS Global Wealth Chief Investment Officer (South Asia Pacific) Kelvin Tay comments on US President Trump’s move to fire the Fed’s Lisa Cook. It wasn’t immediately clear whether Cook intended to challenge the dismissal in the courts.
That investigation marked the latest in a series of moves by the Trump administration both to increase legal scrutiny of Democratic figures and put pressure on the central bank. Cook said Trump has no authority to fire her, and she won’t quit. Cook’s lawyer, Abbe Lowell, said they plan to take “whatever actions are needed to prevent” Trump’s “illegal action.” Cook is likely to sue to challenge the removal and “we believe she can win,” wrote Bloomberg Intelligence analyst Elliott Z Stein. Mere allegations of fraud are likely insufficient to meet the “for cause” removal standard unless actual wrongdoing is established, which at minimum likely requires an investigation and possibly a conviction, he wrote. Risk to the independence of the Fed was also flagged as a concern by S&P Global Ratings earlier this month while affirming the AA+ rating for the US — a score it’s given since 2011, when it first downgraded the world’s largest economy from AAA. Meanwhile, contracts for the Nasdaq 100 fell 0.2% as Trump also threatened to place export curbs on chips.  Stocks were already under pressure after initial optimism about the Fed lowering interest rates vanished and US stocks retreated Monday. Stocks rallied on Friday after Federal Reserve Chair Jerome Powell opened the door for a possible interest-rate cut. The sense of euphoria eased as doubts over the pace of those reductions lingered on Wall Street as traders braced for a not-so-friendly price reading later this week. Policymakers are grappling with inflation that’s still above their 2% goal — and rising — and a labor market that’s showing signs of weakness. That unnerving reality, which pulls policy in opposite directions, is made worse by a high degree of uncertainty about how each of those factors will evolve over the coming months.  The Fed’s preferred gauge of underlying inflation probably ticked higher last month, with the personal consumption expenditures price index excluding food and energy rising 2.9% from a year ago. That would be the fastest annual pace in five months. Elsewhere, French bond futures opened lower after Prime Minister Francois Bayrou called a confidence vote that may topple France’s government as soon as next month. Aside from the macro picture, the next big test for the stock market will be a read on what’s been driving gains for the past few years: artificial-intelligence euphoria. Nvidia Corp. is due to unveil its results Wednesday after the close. The company’s size — it has the biggest weighting in the S&P 500 at almost 8% — and its position at the center of AI development have made it a bellwether for the broader market.  US After Hours IBKR +4.1% to join S&P 500; TLN +4.6% to join S&P MidCap 400; KNTK +5.9% to join S&P SmallCap 600; NVTS +0.5% names a new CEO; HEI +1.1%, SMTC +0.5% slightly higher on earnings.

Nikkei -0.88% Hang Seng -0.12% CSI -0.04% Shanghai -0.07% Shenzen +0.51%

Eur$ 1.1630 CNH 7.1556 CNY 7.1537 JPY 147.87 GBP 1.3454 CHF 0.8058 RUB 80.7193 TRY 41.0218 WTI$ 64.46 -0.52% Gold 3,374 +0.23% BTC 110,255 +0.62% ETH 4,440 +2%

S&P -0.05% Nasdaq -0.10% EuroStoxx -0.39% FTSE -0.27% Dax -0.22% SMI -0.12%

Macro :
- BofA, UBS See Small-Cap Outperformance as Powell Turns Dovish
- Norway’s Wealth Fund Excludes Israeli Banks, Caterpillar
- Crypto Fund Pantera Seeks to Raise Up to $1.25 Billion for Solana Deal
- BlackRock Halts Funding for Private Credit Fund

Keep an eye on :
- AMZN US : The Future of Streaming Is Different Ad Loads for Each Viewer
- AMZN US : Amazon, Korea Hydro to Partner on Small Modular Reactors for AI
- AS US : Amer Sports Holder Anamered Said to Seek $163m in Block Sale
- ARBN SW : Arbonia 1H Ebitda Meets Estimates
- BAKKA NO : Bakkafrost Sees FY Harvest About 104,000 Metric Tons
- BELL SW ; Bell Food Group Names Sven Friedli as CFO
- BIOAB SS : BioArctic, Novartis Sign Option, Collaboration, License Deal
- Bitpanda : Peter Thiel-Backed Bitpanda Rules Out UK Listing: FT
- BA US : Korean Air to Buy $50b Boeing Jets, GE Engines; Shres Drop
- BNZL LN : Bunzl 1H Revenue Matches Estimates
- BWLPG NO : BW LPG 2Q EPS Misses Estimates
- 1211 HK : BYD +3.11%
- CAP FP : Capgemini to Buy Cloud4C; No Terms
- CSX US : CSX Falls on Report Berkshire Not in Market for a Train Firm
- DEME BB : DEME Group 1H Turnover Beats Estimates
- DMP GY : Dermapharm Maintains FY Adjusted Ebitda Forecast
- EPISB SS : Episurf Medical announces final outcome of the rights issue
- GENI LN : GENinCode Says Performance is in Line With Expectations
- GPRO US : GoPro Calls Snapped Up as Shares Surge 36%
- GSF NO : Grieg Seafood Cuts FY Harvest Forecast After Sale of Operations
- IBRK US : *INTERACTIVE BROKERS TO REPLACE WALGREENS IN S&P 500 *INTERACTIVE BROKERS SHARES RISE 5% ON S&P 500 INCLUSION
- IFX GY : Infineon is accelerating the development of humanoid robotics with NVIDIA (NVDA) technology
- ISN SW : Intershop 1H Net Income CHF175.9M Vs. CHF52.7M Y/y
- JDEP NA : Keurig Slides Amid Deal Risks, JAB Cashing Out of JDE Peet
- KUD SW : Kudelski 1H Ebitda Loss $19.1M Vs. Loss $11.7M Y/y
- 3690 HK : Meituan Likely to Post Big Profit Decline in Food Wars: Preview
- MNG LN : M&G, Schroders, Hargreaves Lansdown Eye Master Trust Market: FT
- NOVN SW : BioArctic, Novartis Sign Option, Collaboration, License Deal
- ORSTED DC : Orsted Faces Growing Crisis After Trump Halts Work at Wind Farm
- ORSTED DC : Orsted Seeks to Calm Investors Ahead of $9.4 Billion Share Sale
- 1913 HK : Prada +2.88%
- ROG SW : Roche Breaks Ground on North Carolina Obesity Drug Factory
- Space X : SpaceX Delays Starship Launch Due to Unfavorable Weather
- TEF SM : Telefonica Main Holders Back Vodafone Espana Deal: Confidencial
- VLA FP : Vaccine Stocks Down After Report on Push to Scrap Covid Shots
- VAR NO : Var Reaches 400,000 boepd Output Milestone Ahead of Schedule
- WG/ LN : Dubai's Sidara Consortium Cuts Wood Group Offer Price After Completing Due Diligence
- 9868 HK : XPeng : +2.57%
- YAR NO : Fertilizer Stocks Rise on USGS’ Critical-Minerals Proposal
- ZEAL DC : Roche Breaks Ground on North Carolina Obesity Drug Factory
- FHZN SW : Zurich Airport 1H Ebitda Beats Estimates

>>> Stoxx 600 Pre-Market Indications

  • Bouygues (BYG TH) +0.9%
    • Bouygues Overhangs Clearing, JPMorgan Upgrades to Overweight
  • Orsted (D2G TH) +0.8%
    • Orsted Seeks to Calm Investors Ahead of $9.4 Billion Share Sale
  • BNP Paribas (BNP TH) -1.2%
    • Watch French Stocks as Political Risks Make Sudden Comeback
  • Leonardo (FMNB TH) -1.3%
  • BBVA (BOY TH) -1.4%
  • Novo (NOV TH) -1.4%
  • Nordea Bank (04Q TH) -1.5%
  • EssilorLuxottica (ESL TH) -1.5%
  • Puma (PUM TH) -1.6%
    • Pinault Family Is Said to Mull Options for Puma Sports Brand (3)
  • Commerzbank (CBK TH) -2.3%
    • Downgrade to Underperform at Bofa